Abbott, the global healthcare leader, and Novo, a global leader in treatments for serious chronic diseases, have announc...
Boehringer Ingelheim, headquartered in Germany, and China-based Sino Biopharmaceutical (together with its subsidiaries, ...
Japan-based Nxera Pharma has announced that its subsidiary, Nxera Pharma UK, has entered into an exclusive global licens...
Cell and gene therapies are redefining treatment possibilities, yet fragmented manufacturing processes, complex referral...
Start with the smallest story of the year, because it may turn out to be the most important. Until this summer, Mithril ...
--Charles River Laboratories’ third-quarter results offer CEO Birgit Girshick stronger evidence of impro...
As autoimmune and allergic diseases present increasingly complex diagnostic challenges, laboratories face growing pressu...
BIOPLUS-INTERPHEX KOREA 2026 closed at COEX on Friday with its shortest conference day and, in some ways, its most forwa...
Asia-Pacific carries a disproportionate burden of drug-resistant infections. The World Health Organization’s (WHO)...
In 2026, Novo Nordisk’s Awiqli became the first once-weekly basal insulin to receive approval from the US Food and...
Regenerative medicine is entering a defining phase as stem-cell research moves beyond laboratory discoveries towards cli...
American multinational pharmaceutical company Merck (Known as Merck Sharp & Dohme or MSD outside the United States a...
If Day 1 of BIX 2026 asked what makes a Korean asset partnerable, Day 2 asked what happens once someone wants it. Thursd...
Ask most investors to name South Korea's bio clusters and the list starts with Songdo, moves on to Pangyo and Osong, and...
Brain–computer interfaces (BCIs) are entering a new phase of technological development, moving beyond experimental...
Japan-based Astellas Pharma Inc. has entered into an exclusive option and license agreement for DAX-044, Audax’s l...
PeptiDream Inc., a public biopharmaceutical company based in Kawasaki, Japan, focused on the discovery and development o...
CELSET INC., a Korean biotechnology company specialising in medical aesthetics, has launched SOLTOX, its botulinum toxin...
Japan-based Otsuka Pharmaceutical has announced that Otsuka BioVentures, LLC (OBV), a corporate venture capital (CVC) fi...
US-based Gilead Sciences, Inc. has entered into a definitive agreement to acquire an oral IL-23R inhibitor programme, in...
MedTech Innovator (MTI), the world’s largest accelerator of medical device, digital health, and diagnostic compani...
United Imaging Healthcare's uMR Jupiter 5T MRI system has been officially introduced at Hanoi Medical University Hospita...
US-based Natus Medical Incorporated, the world's largest pure-play neurodiagnostic company, recently celebrated the gran...
US-based Labcorp, a global leader of innovative and comprehensive laboratory services, and Waters Corporation, a global ...
Kaigene, Inc., a US-based biotechnology company developing antibody medicines for autoimmune diseases, has announced an ...
